Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Bone marrow angiogenesis in multiple myeloma.

A Vacca¹, D Ribatti

¹Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.

|December 17, 2005

Summary

Multiple myeloma (MM) progression involves angiogenesis, driven by plasma cells and complex microenvironmental interactions. Understanding this process is key to developing new treatments for this plasma cell cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surviving adversity: Exploring the presence of Lunularia cruciata (L.) Dum. on metal-polluted mining waste.

Plant biology (Stuttgart, Germany)·2024

Same author

Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.

European review for medical and pharmacological sciences·2023

Same author

Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation.

Advances in experimental medicine and biology·2022

Same author

Cardiovascular Risk Score and Pulmonary Gas Exchange in COVID-19 Patients Show No Correlation.

Advances in experimental medicine and biology·2022

Same author

Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.

European review for medical and pharmacological sciences·2022

Same author

Development of pectoral muscle atrophy in critically ill patients.

Medicina intensiva·2022

Area of Science:

Oncology
Hematology
Cell Biology

Background:

Angiogenesis, the formation of new blood vessels, is a critical factor in the progression of multiple myeloma (MM).
The transition from monoclonal gammopathy of undetermined significance (MGUS) to MM is associated with increased angiogenesis, potentially due to reduced angiostatic activity.
The complex pathophysiology involves direct cytokine production by plasma cells and induction within the bone marrow microenvironment.

Purpose of the Study:

To elucidate the multifaceted role of angiogenesis in multiple myeloma progression.
To understand the contribution of plasma cells and the bone marrow microenvironment to MM-induced angiogenesis.
To explore the prognostic significance of angiogenesis in multiple myeloma.

Main Methods:

Review of existing literature on angiogenesis in multiple myeloma.
Analysis of the molecular mechanisms driving angiogenesis in the MM microenvironment.
Investigation of the role of various cell types, including plasma cells, stromal cells, endothelial cells, osteoclasts, and inflammatory cells.

Main Results:

Plasma cells induce angiogenesis through direct secretion of angiogenic factors and by stimulating the bone marrow microenvironment.
Stromal cells, endothelial cells, and osteoclasts contribute to angiogenesis by secreting factors that promote plasma cell growth, survival, and migration.
Inflammatory cells and circulating endothelial precursor cells (EPCs) also support neovascularization, with EPCs potentially contributing to vasculogenesis.

Conclusions:

Angiogenesis is a fundamental process in multiple myeloma progression with significant prognostic implications.
The intricate interplay between plasma cells and the bone marrow microenvironment orchestrates MM-induced angiogenesis.
Targeting angiogenesis presents a potential therapeutic strategy for multiple myeloma.

Related Experiment Videos